438 related articles for article (PubMed ID: 18511457)
21. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.
Fakhfakh R; Lee SJ; Tremblay JP
Cell Transplant; 2012; 21(7):1419-30. PubMed ID: 22449443
[TBL] [Abstract][Full Text] [Related]
22. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells.
Bachrach E; Li S; Perez AL; Schienda J; Liadaki K; Volinski J; Flint A; Chamberlain J; Kunkel LM
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3581-6. PubMed ID: 14993597
[TBL] [Abstract][Full Text] [Related]
23. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
24. Autologous transplantation of SM/C-2.6(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice.
Ikemoto M; Fukada S; Uezumi A; Masuda S; Miyoshi H; Yamamoto H; Wada MR; Masubuchi N; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2007 Dec; 15(12):2178-85. PubMed ID: 17726457
[TBL] [Abstract][Full Text] [Related]
25. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
[TBL] [Abstract][Full Text] [Related]
26. Cell and gene therapy in Duchenne muscular dystrophy.
Morgan JE
Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
[TBL] [Abstract][Full Text] [Related]
27. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
29. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
[TBL] [Abstract][Full Text] [Related]
30. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle.
Gibson AJ; Karasinski J; Relvas J; Moss J; Sherratt TG; Strong PN; Watt DJ
J Cell Sci; 1995 Jan; 108 ( Pt 1)():207-14. PubMed ID: 7738097
[TBL] [Abstract][Full Text] [Related]
31. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
[TBL] [Abstract][Full Text] [Related]
32. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
Alexander MS; Kawahara G; Motohashi N; Casar JC; Eisenberg I; Myers JA; Gasperini MJ; Estrella EA; Kho AT; Mitsuhashi S; Shapiro F; Kang PB; Kunkel LM
Cell Death Differ; 2013 Sep; 20(9):1194-208. PubMed ID: 23764775
[TBL] [Abstract][Full Text] [Related]
35. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
37. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis.
Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN
Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423
[TBL] [Abstract][Full Text] [Related]
38. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of myogenic differentiation factors and skeletal muscle proteins in human amnion-derived cells via the forced expression of MYOD1.
Akizawa Y; Kanno H; Kawamichi Y; Matsuda Y; Ohta H; Fujii H; Matsui H; Saito K
Brain Dev; 2013 Apr; 35(4):349-55. PubMed ID: 22727434
[TBL] [Abstract][Full Text] [Related]
40. A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation.
Arpke RW; Darabi R; Mader TL; Zhang Y; Toyama A; Lonetree CL; Nash N; Lowe DA; Perlingeiro RC; Kyba M
Stem Cells; 2013 Aug; 31(8):1611-20. PubMed ID: 23606600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
